Market Research Report
Big Data in Pharmaceuticals - Thematic Research
|Big Data in Pharmaceuticals - Thematic Research|
Published: March 31, 2022
Content info: 51 Pages
Delivery time: 1-2 business days
This report provides an overview of the big data analytics in the pharma industry.
Big data is generated in vast quantities across healthcare
The healthcare and pharmaceutical industries generate data in abundance from a multitude of sources including physician notes, pathology reports, electronic health records (EHR), patient registries, genomics, clinical trials, social media, wearable devices, and many more. The dataset in question is huge in both size and complexity, rendering traditional data management techniques inefficient for processing.
In response to this problem, a burgeoning industry has become established around the development of technologies and tools that secure, store, process, analyze, aggregate, and integrate large quantities of data such that they can be used to generate new insights. Big data analytics serve as the engine for other emerging technologies such as artificial intelligence (AI), Internet of Things (IoT), 5G, and cloud.
Pharma can utilize big data across its value chain
The identification of patterns, trends, and associations within these datasets are expected to revolutionize the pharma industry. There are numerous use cases for big data analytics in this sector, including the acceleration of drug discovery and development, optimization of manufacturing processes, supply chain management, and the creation of innovative sales and marketing strategies.
This report assesses how big data analytics, combined with other emerging technologies, can be used across the pharma value chain. It provides an overview of the current landscape, including healthcare, technology, regulatory, and macroeconomic trends, as well as key players, while also highlighting opportunities for the use of big data analytics in the future. The report provides an industry-specific analysis based on GlobalData databases and surveys, as well as several pharma-specific case studies. Finally, the report provides an analysis of big data-related deals, jobs, and social media activity, highlighting the impact of the COVID-19 pandemic, where relevant.